Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Pharmaceutica Sinica ; (12): 346-349, 2003.
Artigo em Chinês | WPRIM | ID: wpr-251088

RESUMO

<p><b>AIM</b>To study asymmetric total synthesis of 14-nor-huperzine A 2 and its inhibitory activity on acetylcholinesterase.</p><p><b>METHODS</b>Highly enantioselective synthesis of compound 5 from beta-keto-ester 3 and 2-methylene-1,3-propanediol diacetate 4 by palladium-catalyzed bicycloannulation was carried out using new chiral ferrocenylphosphine ligands, such as 10, 11, followed by regioselective double-bond migration to produce compound 6. Optically pure 6 was obtained after enantio-enrichment recrystallization. Then, according to similar procedures of huperzine A synthesis, the target compound 14-nor-huperzine A 2 was prepared. The inhibitory activity was tested with rat erythrocyte membrame acetylcholinesterase.</p><p><b>RESULTS</b>The inhibitory activity of synthetic (-)-14-nor-huperzine A was 8 fold less potent than that of (-)-huperzine A.</p><p><b>CONCLUSION</b>A hydrogen-bond between 14-methyl group of (-) huperzine A and the main-chain oxygen of His 440 is necessary for the highly acetylcholinesterase inhibitory activity of huperzine A.</p>


Assuntos
Animais , Ratos , Acetilcolinesterase , Metabolismo , Alcaloides , Doença de Alzheimer , Tratamento Farmacológico , Inibidores da Colinesterase , Farmacologia , Usos Terapêuticos , Membrana Eritrocítica , Conformação Molecular , Estrutura Molecular , Sesquiterpenos , Química , Farmacologia , Usos Terapêuticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA